Led by researchers at Imperial College London, the project follows previous analysis of food biomolecules and existing drugs to fight cancer and COVID-19.
- Latest project from Vodafone Foundation’s DreamLab app to use AI to identify “hyperfoods” and existing drugs to fight long COVID.
- Led by researchers at Imperial College London, the project follows previous analysis of food biomolecules and existing drugs to fight cancer and COVID-19.
- To be completed in late 2023, the study will be powered by DreamLab, a crowdsourcing app that uses the processing power of mobile phones to speed up scientific research.
- Download DreamLab for free now in the App Store for iOS or Play Store for Android.
Vodafone Foundation’s DreamLab app will support researchers at Imperial College London by using AI and machine learning to uncover how dietary biomolecules and phytochemically rich “hyperfoods” can help to fight long COVID.
One of the first studies exploring the link between biomolecules in the foods we eat and long COVID, the research has been made possible through Vodafone Foundation’s free and secure app DreamLab. The app harnesses your smartphone’s idle processing power to analyse complex data on behalf of the researchers while you sleep.
Dr Kirill Veselkov, Assistant Professor at Imperial College London, is leading a team of researchers at the university to develop critical analysis for long COVID as part of the new ‘DreamLab long COVID project’. The DreamLab mobile supercomputing technology has previously helped to uncover hundreds of biomolecules in foods against specific types of cancers and COVID-19.
“Combining the processing power of tens of thousands of smartphones, the DreamLab app drastically reduces the time taken to analyse such vast amounts of data. While it would have taken decades using traditional computing methods, the cloud-based network can crunch the same amount of data in months.